Journal of Cancer Research and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.4 | Q4 | 14.1% | 0.425 | Q3 | 55.3% |
| 2024 | 1.3 | Q4 | 16.6% | 0.468 | Q2 | 60.0% |
| 2023 | 1.4 | Q4 | 18.7% | 0.427 | Q3 | 59.8% |
| 2022 | 1.3 | Q4 | 14.8% | 0.353 | Q3 | 55.6% |
| 2021 | 1.3 | Q4 | 28.6% | 0.363 | Q3 | 57.3% |
| 2020 | — | — | 0.475 | Q3 | 64.7% | |
| 2019 | — | — | 0.461 | Q2 | 65.1% | |
| 2018 | — | — | 0.420 | Q3 | 60.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0973-1482
ISSN
1998-4138
country
INcoverage
2005-2025